Growth Metrics

Praxis Precision Medicines (PRAX) Accumulated Depreciation & Amortization (2022 - 2025)

Praxis Precision Medicines has reported Accumulated Depreciation & Amortization over the past 4 years, most recently at $1.5 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $1.5 million for Q4 2025, up 10.2% from a year ago — trailing twelve months through Dec 2025 was $1.5 million (up 10.2% YoY), and the annual figure for FY2025 was $1.5 million, up 10.2%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $1.5 million at Praxis Precision Medicines, up from $1.4 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for PRAX hit a ceiling of $1.5 million in Q4 2025 and a floor of $572000.0 in Q4 2022.
  • Median Accumulated Depreciation & Amortization over the past 4 years was $1.2 million (2023), compared with a mean of $1.1 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 75.7% in 2023 and later rose 10.2% in 2025.
  • Praxis Precision Medicines' Accumulated Depreciation & Amortization stood at $572000.0 in 2022, then surged by 75.7% to $1.0 million in 2023, then surged by 35.62% to $1.4 million in 2024, then rose by 10.2% to $1.5 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $1.5 million (Q4 2025), $1.4 million (Q4 2024), and $1.0 million (Q4 2023) per Business Quant data.